Last reviewed 2026-04-22 · How we verify

Individualized therapy

Individualized therapy refers to personalized treatment approaches tailored to a patient's specific disease characteristics, genetic profile, and clinical parameters rather than a single standardized drug mechanism.

At a glance

Mechanism of action

This is a therapeutic strategy rather than a specific drug, where treatment selection and dosing are customized based on individual patient factors including biomarkers, pharmacogenomics, disease stage, and comorbidities. The approach aims to optimize efficacy and minimize adverse effects by matching the right intervention to the right patient at the right time.

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

• WEB-BASED FILIAL THERAPY IN PEDIATRIC CANCER (NA)
• Shared Decision-Making Decision Aid for Newly Diagnosed Breast Cancer : A Multi-Center Randomized Controlled Trial (NA)
• A Natural History of Genetic and Environmental Predictors of Pubertal Timing Among Youth With Obesity
• Using Technology to Investigate Lapses in a Weight Loss Program Among Individuals With Overweight and Obesity (NA)
• Individualized Precision Isavuconazole Therapy Guided by PK/PD Principles for the Geriatric Population
• IASTM and Vibration Effects on Pain, Functionality, and Kinesiophobia in Lumbar Disc Herniation (NA)
• Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal Histologies (PHASE1)
• Evidence-Based Nursing Plus Progressive Exercise for Cancer-Related Fatigue in Advanced Lung Cancer (NA)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.